2010Asian Journal of Research in ChemistryRequires access

Simultaneous Estimation and Validation of Amlodipine Besylate and Nebivolol Hydrochloride in Tablet Formulation by RP-HPLC Method

M. Jagadeeswaran, N. Madana Gopal, Sivakumar Thangavel

Open publisher page 1 citations

Abstract

A simple, selective and rapid reversed phase high performance liquid chromatographic (RP-HPLC) method has been developed for the simultaneous estimation of Amlodipine Besylate and Nebivolol Hydrochloride from their tablet formulation. The method is carried out on a nucleosil C18 (25 cm×4.6 mm) column with the mobile phase consisting of 0.01M tetra butyl ammonium hydrogen sulphate: acetonitrile (60:40 v/v) and adjusted the pH to 3.0 by using trimethyl amine, at the flow rate of 1.0 ml min−1. Detection is performed at 264 nm. The retention time of Amlodipine Besylate and Nebivolol Hydrochloride was 2.55 and 5.44 min respectively. The developed method was validated for linearity, accuracy, precision, solution stability, robustness, limit of detection, and limit of quantification. The proposed method can be used for routine analysis of drugs in combined dosage forms.

About this research paper

What this paper is about

A simple, selective and rapid reversed phase high performance liquid chromatographic (RP-HPLC) method has been developed for the simultaneous estimation of Amlodipine Besylate and Nebivolol Hydrochloride from their tablet formulation. The method is carried out on a nucleosil C18 (25 cm×4.6 mm) column with the mobile phase consisting of 0.01M tetra butyl ammonium hydrogen sulphate: acetonitrile (60:40 v/v) and adjusted the pH to 3.0 by using trimethyl amine, at the flow rate of 1.0 ml min−1. Detection is performed at 264 nm. The retention time of Amlodipine Besylate and Nebivolol Hydrochloride was 2.55 and 5.44 min respectively. The developed method was validated for linearity, accuracy, precision, solution stability, robustness, limit of detection, and limit of quantification. The proposed method can be used for routine analysis of drugs in combined dosage forms.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A simple, selective and rapid reversed phase high performance liquid chromatographic (RP-HPLC) method has been developed for the simultaneous estimation of Amlodipine Besylate and Nebivolol Hydrochloride from their tablet formulation. The method is carried out on a nucleosil C18 (25 cm×4.6 mm) column with the mobile phase consisting of 0.01M tetra butyl ammonium hydrogen sulphate: acetonitrile (60:40 v/v) and adjusted the pH to 3.0 by using trimethyl amine, at the flow rate of 1.0 ml min−1. Detection is performed at 264 nm. The retention time of Amlodipine Besylate and Nebivolol Hydrochloride was 2.55 and 5.44 min respectively. The developed method was validated for linearity, accuracy, precision, solution stability, robustness, limit of detection, and limit of quantification. The proposed method can be used for routine analysis of drugs in combined dosage forms.

Key concepts: Amlodipine, Chromatography, Detection limit, Chemistry, Nebivolol, High-performance liquid chromatography, Acetonitrile, Pharmaceutical formulation

Related papers

Back to paper searchBrowse research topicsOriginal source
Simultaneous Estimation and Validation of Amlodipine Besylate and Nebivolol Hydrochloride in Tablet Formulation by RP-HPLC Method — Research Paper | ScholarLens